Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer
NCT02869282 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-09-17
Summary
Multicentric, observational, prospective, non-interventional study with occasional biological sample collection (serum bank, urine bank and tumor bank)
Conditions
Interventions
- OTHER
-
Blood samples
Additional blood samples at baseline, 6, 12, 18 and 24 months.
- OTHER
-
Urine samples
Additional urine samples at baseline, 6, 12, 18 and 24 months.
Sponsors & Collaborators
-
Institut Bergonié
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- France
Study Locations
More Related Trials
-
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand
NCT04266392 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00124917 ·Status: TERMINATED ·Phase: PHASE1
-
Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney
NCT06214000 ·Status: COMPLETED
-
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
NCT01492972 ·Status: RECRUITING ·Phase: PHASE3
-
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
NCT03494803 ·Status: WITHDRAWN
-
Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer
NCT01704027 ·Status: TERMINATED ·Phase: PHASE2
-
Genetics of Prostate Cancer in Young Patients
NCT06714227 ·Status: COMPLETED
-
Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model
NCT03979079 ·Status: COMPLETED
-
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02594202 ·Status: RECRUITING
-
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
NCT00991315 ·Status: TERMINATED
-
Investigation of Protein Biomarkers of Prostate Cancer
NCT00323180 ·Status: WITHDRAWN
-
Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk
NCT01717677 ·Status: TERMINATED ·Phase: NA
-
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
NCT02282644 ·Status: COMPLETED ·Phase: NA
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer
NCT02710721 ·Status: COMPLETED ·Phase: NA
-
PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer
NCT04983459 ·Status: COMPLETED
-
Validation of the Prostate Cancer Assay - Beta+Pivotal
NCT02742259 ·Status: WITHDRAWN
-
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT04457245 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
NCT06700057 ·Status: RECRUITING
-
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr
NCT02689271 ·Status: COMPLETED
-
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)
NCT04638049 ·Status: COMPLETED ·Phase: NA
-
68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated
NCT02920229 ·Status: COMPLETED ·Phase: NA
-
Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
NCT02935023 ·Status: UNKNOWN ·Phase: PHASE2
-
Validation of Radioisotope Guided Lymphadenectomy for Loco-regional Staging in Patients With Intermediate or High-risk Prostate Cancer
NCT02732392 ·Status: COMPLETED ·Phase: NA
-
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
NCT04298112 ·Status: COMPLETED